Broadcasting News

Kim Mu-yeol of “True Education” to Hold First Official Fan Meeting… “Face to Face” on the 23rd of Next Month

To be held at Gabin Art Hall… General ticket sales begin on the 24th

KIM HYUNSIK
2026-07-18 14:25:16
[Edaily Starin KIM HYUNSIK Reporter] Actor Kim Mu-yeol is holding a fan meeting.
(Photo courtesy of Prain TPC)
According to his agency, Prain TPC, on the 18th, Kim Mu-yeol will hold his first official fan meeting, titled “Maju,” at 3:00 p.m. on the 23rd of next month at Gavin Art Hall.
The fan meeting’s title, “Maju,” reflects his desire to “get closer to his fans’ hearts.”
The agency stated, “Kim Mu-yeol plans to spend time connecting with fans through various stories, performances, and activities.”
Since his debut in 1999, Kim Mu-yeol has built up a diverse filmography by working across various fields, including dramas, films, and musicals. His notable works include the musicals *Kinky Boots* and *Thrill Me*, the dramas *Bad Guys: City of Evil* and *Trolley*, the Netflix series *Juvenile Court* and *Sweet Home Seasons 2 & 3*, and the films *The Last Archer*, *Night of Memory*, *The Villain*, *Top Secret*, and *The Roundup 4*.
Most recently, he gained popularity through his role in the Netflix series “True Education.” Kim Mu-yeol played the role of Na Hwa-jin, an inspector with the Office for the Protection of Teachers’ Rights, and helped drive the show’s massive success.
Tickets for the fan meeting “Maju” will be sold exclusively through Ticketlink. General ticket sales will begin at 8:00 p.m. on the 24th. Detailed information regarding fan meeting ticket reservations can be found on Red Sleepers’ social media channels.

Economy

Corporation

IT·Science

Economy

[VC’s Pick] “Humans and Robots Working Together”… Holiday Robotics Secures Investment

This week (July 13–16), startups across various sectors—including beauty brands, chat platforms, and AI-based decision-making and data infrastructure—secured investments from venture capital (VC) firm…
2026-07-18 12:08:04

Corporation

[Clinical Update] Celltrion Receives Approval for Phase 1 Trial of Tremfya Biosimilar ‘CT-P68’ in South Korea

Here are the clinical trial and product approval updates that garnered attention in the domestic pharmaceutical and biotech industry this week (July 13–16). (Photo: AI-generated) CelltrionRece…
2026-07-18 07:01:02

IT·Science

PharmaResearch, Equipped with U.S.-Based CG USA, Accelerates Expansion into the U.S. ... What Is the Strategy for Reaching 1 Trillion Won in Sales?

PharmaResearch(214450)is staking its future on expanding into North America—the world’s largest beauty market—despite concerns over stagnant growth in its domestic market. At the same time, attention …
2026-07-17 08:36:02